Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00169455
Status:
COMPLETED
Last Update Posted:
2017-01-16
First Post:
2005-09-09
Brief Title:
Assess the Immunogenicity of the Human Rotavirus HRV Vaccine After Reconstitution Without Buffering Agent Evaluate the Immunogenicity Reactogenicity Safety of the Vaccine After Storage for 7 d at 37C Following 2 Doses in Healthy Infants
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Organization Data
Organization:
GlaxoSmithKline
Class:
INDUSTRY
Study ID:
103477
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GlaxoSmithKline
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None